Overview
EPHB4-related lymphatic-related hydrops fetalis (also sometimes called EPHB4-related hydrops fetalis or LRHF) is a rare genetic condition that affects how fluid is managed in the body, particularly in unborn babies and newborns. It is caused by changes (mutations) in the EPHB4 gene, which plays an important role in the development of the lymphatic system — the network of vessels that helps drain excess fluid from body tissues. When this system does not work properly, fluid builds up in abnormal places, a condition called hydrops fetalis. This means fluid collects under the skin, around the lungs, around the heart, or in the belly of the baby before or shortly after birth. Babies with this condition may be identified before birth through routine ultrasound scans that show unusual fluid buildup. The severity can vary widely — some babies are severely affected and may not survive, while others may respond to treatment and improve over time. The lymphatic system problems can also cause ongoing issues with fluid drainage after birth, sometimes leading to swelling (lymphedema) in the limbs or other areas. Treatment is focused on managing symptoms. Before birth, doctors may drain excess fluid to help the baby breathe and develop. After birth, care is provided in a neonatal intensive care unit (NICU), and longer-term management of lymphatic problems may involve compression therapy, specialized physical therapy, and close monitoring. There is currently no cure, but research into this condition is growing as more cases are identified.
Also known as:
Key symptoms:
Abnormal fluid buildup throughout the body before or after birth (hydrops fetalis)Swelling under the skin (edema)Fluid around the lungs (pleural effusion)Fluid around the heart (pericardial effusion)Fluid in the belly (ascites)Swelling of the limbs due to lymphatic problems (lymphedema)Breathing difficulties at birthEnlarged placentaSkin thickening or puffinessLow protein levels in the blood
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for EPHB4-related lymphatic-related hydrops fetalis.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for EPHB4-related lymphatic-related hydrops fetalis at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for EPHB4-related lymphatic-related hydrops fetalis.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to EPHB4-related lymphatic-related hydrops fetalis.
Community
No community posts yet. Be the first to share your experience with EPHB4-related lymphatic-related hydrops fetalis.
Start the conversation →Latest news about EPHB4-related lymphatic-related hydrops fetalis
No recent news articles for EPHB4-related lymphatic-related hydrops fetalis.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.What specific change was found in the EPHB4 gene, and what does it mean for my child's health?,What is the likelihood that future pregnancies will be affected, and what prenatal testing options are available?,What specialists should be part of my child's care team, and how often should we have follow-up appointments?,Are there any clinical trials or experimental treatments we should know about?,What signs of complications should prompt us to seek emergency care?,What long-term lymphatic problems should we expect, and how are they best managed?,Are there patient support groups or family networks for EPHB4-related conditions?
Common questions about EPHB4-related lymphatic-related hydrops fetalis
What is EPHB4-related lymphatic-related hydrops fetalis?
EPHB4-related lymphatic-related hydrops fetalis (also sometimes called EPHB4-related hydrops fetalis or LRHF) is a rare genetic condition that affects how fluid is managed in the body, particularly in unborn babies and newborns. It is caused by changes (mutations) in the EPHB4 gene, which plays an important role in the development of the lymphatic system — the network of vessels that helps drain excess fluid from body tissues. When this system does not work properly, fluid builds up in abnormal places, a condition called hydrops fetalis. This means fluid collects under the skin, around the lun
How is EPHB4-related lymphatic-related hydrops fetalis inherited?
EPHB4-related lymphatic-related hydrops fetalis follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does EPHB4-related lymphatic-related hydrops fetalis typically begin?
Typical onset of EPHB4-related lymphatic-related hydrops fetalis is neonatal. Age of onset can vary across affected individuals.